Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Breitner

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Neurology|April 2, 2020
Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer diseaseJohn Breitner, Pierre-Francois Meyer
The American Journal of Medicine|March 14, 2007
ADAPT trial dataJohn Breitner, Denis Evans, Constantine Lyketsos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2019
Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathologyPierre-François Meyer, Melissa Savard, Judes Poirier, et al.
Neurobiology of Aging|July 27, 2019
Association of PPP2R1A with Alzheimer's disease and specific cognitive domainsJustin Miron, Cynthia Picard, Anne Labonté, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2017
Dementia registries around the globe and their applications: A systematic reviewKarolina Krysinska, Perminder S Sachdev, John Breitner, et al.
JAMA|September 24, 2002
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health studyConstantine G Lyketsos, Oscar Lopez, Beverly Jones, et al.
Neurobiology of Aging|June 29, 2014
Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's diseaseJudes Poirier, Justin Miron, Cynthia Picard, et al.
Journal of Neuroinflammation|July 10, 2014
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imagingEduardo Rigon Zimmer, Antoine Leuzy, Andréa Lessa Benedet, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2024
Contactin 5 and Apolipoproteins Interplay in Alzheimer's DiseaseMarina Tedeschi Dauar, Cynthia Picard, Anne Labonté, et al.
Gigascience|May 12, 2019
A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementiaAngela Tam, Christian Dansereau, Yasser Iturria-Medina, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Neurology|April 2, 2020
Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer diseaseJohn Breitner, Pierre-Francois Meyer
The American Journal of Medicine|March 14, 2007
ADAPT trial dataJohn Breitner, Denis Evans, Constantine Lyketsos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2019
Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathologyPierre-François Meyer, Melissa Savard, Judes Poirier, et al.
Neurobiology of Aging|July 27, 2019
Association of PPP2R1A with Alzheimer's disease and specific cognitive domainsJustin Miron, Cynthia Picard, Anne Labonté, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2017
Dementia registries around the globe and their applications: A systematic reviewKarolina Krysinska, Perminder S Sachdev, John Breitner, et al.
JAMA|September 24, 2002
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health studyConstantine G Lyketsos, Oscar Lopez, Beverly Jones, et al.
Neurobiology of Aging|June 29, 2014
Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's diseaseJudes Poirier, Justin Miron, Cynthia Picard, et al.
Journal of Neuroinflammation|July 10, 2014
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imagingEduardo Rigon Zimmer, Antoine Leuzy, Andréa Lessa Benedet, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2024
Contactin 5 and Apolipoproteins Interplay in Alzheimer's DiseaseMarina Tedeschi Dauar, Cynthia Picard, Anne Labonté, et al.
Gigascience|May 12, 2019
A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementiaAngela Tam, Christian Dansereau, Yasser Iturria-Medina, et al.
Pageof 4